| For: | Dutt K, Vasudevan A, Hodge A, Nguyen TL, Srinivasan AR. Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review. World J Gastroenterol 2025; 31(24): 107661 [PMID: 40599191 DOI: 10.3748/wjg.v31.i24.107661] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i24/107661.htm |
| Number | Citing Articles |
| 1 |
Giuseppe Blando, Arianna Toscano, Anna Viola, Laura Patanè, Sabrina Verachtert, Carmela Morace, Giovanni Squadrito, Giuseppe Mandraffino, Angela Alibrandi, Walter Fries, Giuseppe Costantino. Cardiovascular Risk Assessments and Ultrasound-Assisted Re-Stratification in Patients with Inflammatory Bowel Disease (IBD). Gastrointestinal Disorders 2025; 7(4) doi: 10.3390/gidisord7040059
|
| 2 |
Eva Karaskova, David Friedecky, David Kleparnik, Adela Palkovska, Radana Brumarova, David Karasek. Cardiovascular risk in inflammatory bowel disease: focus on lipids and visceral adipose tissue. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1860937
|
| 3 |
Lucia Acampora, Federica Restolfer, Pierluigi De Pierro, Maria Masulli, Monica Dentice, Giovanni Sarnelli, Annunziata Gaetana Cicatiello. The gut-thyroid axis: physiological regulation of barrier function, microbiota, endocrine signaling and the consequences on energy metabolism. Frontiers in Physiology 2026; 17 doi: 10.3389/fphys.2026.1753136
|
| 4 |
Shanshan Huang, Yuxia Pan, Zhudong Liu, Yanhua Liang, Shanyu Qin, Haixing Jiang. Individual components and cumulative burden of metabolic syndrome are associated with higher disease activity and adverse outcomes in Crohn’s disease. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1721566
|
| 5 |
Raseen Tariq, Kavin Parmar, Mahima Desai, Richard K. Sterling, Arun J. Sanyal. Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real‐World Cohort Study. United European Gastroenterology Journal 2026; 14(6) doi: 10.1002/ueg2.70255
|